scholarly journals Very late vasomotor responses and gene expression with bioresorbable scaffolds and metallic drug‐eluting stents

2021 ◽  
Author(s):  
Jin‐Sin Koh ◽  
Bill D. Gogas ◽  
Sandeep Kumar ◽  
James J. Benham ◽  
Sanjoli Sur ◽  
...  
Keyword(s):  
Gene Expression ◽  
Drug Eluting Stents ◽  
Vasomotor Responses ◽  
Bioresorbable Scaffolds ◽  
Drug Eluting

scholarly journals The role of optical coherence tomography guidance in scaffold versus stent optimization

2020 ◽  
Vol 72 (1) ◽  
Author(s):  
Arif A. Al Nooryani ◽  
Nagwa A. Abdelrahman ◽  
Hatem A. Helmy ◽  
Yehia T. Kishk ◽  
Ayman K. M. Hassan
Keyword(s):  
Decision Making ◽  
Optical Coherence Tomography ◽  
Coronary Intervention ◽  
Drug Eluting Stents ◽  
Optical Coherence ◽  
Total Rate ◽  
Great Ability ◽  
Bioresorbable Scaffolds ◽  
Drug Eluting ◽  
The Impact

Abstract Background Optical coherence tomography showed a great ability to identify adverse features during percutaneous coronary intervention with drug-eluting stents and resulted in better clinical outcomes. The study aimed to assess the impact of optical coherence tomography on intraoperative decision-making during implantation of Absorb bioresorbable scaffolds versus everolimus drug-eluting stents. Results We performed an observational study that included 223 consecutive patients post optical coherence tomography-guided implantation of either Absorb bioresorbable scaffolds (162 patients) or everolimus drug-eluting stents (61 patients). We studied the influence of optical coherence tomography on intraoperative decision-making during implantation of bioresorbable scaffolds versus drug-eluting stents by analyzing the total rate of optical coherence tomography-dependent modifications in each device. After satisfactory angiographic results, the total rate of required intervention for optical coherence tomography detected complications was significantly higher in the bioresorbable scaffolds arm compared to drug-eluting stents arm (47.8% versus 32.9%, respectively; p = 0.019). The additional modifications encompassed further optimization in the case of device underexpansion or struts malapposition, and even stenting in the case of strut fractures, or significant edge dissection. Conclusions Compared to drug-eluting stents, Absord scaffold was associated with a significantly higher rate of optical coherence tomography-identified intraprocedural complications necessitating further modifications. The study provides some hints on the reasons of scaffolds failure in current PCI practice; it offers a new insight for the enhancement of BRS safety and presents and adds to the growing literature for successful BRS utilization.

scholarly journals Stent Thrombosis With Drug-Eluting Stents and Bioresorbable Scaffolds

2016 ◽  
Vol 9 (12) ◽  
pp. 1203-1212 ◽  
Author(s):  
Si-Hyuck Kang ◽  
In-Ho Chae ◽  
Jin-Joo Park ◽  
Hak Seung Lee ◽  
Do-Yoon Kang ◽  
...  
Keyword(s):  
Stent Thrombosis ◽  
Drug Eluting Stents ◽  
Bioresorbable Scaffolds ◽  
Drug Eluting

scholarly journals Bioresorbable Scaffolds Versus Metallic Drug-Eluting Stents

2015 ◽  
Vol 66 (21) ◽  
pp. 2310-2314 ◽  
Author(s):  
Stephan Windecker ◽  
Konstantinos C. Koskinas ◽  
George C.M. Siontis
Keyword(s):  
Drug Eluting Stents ◽  
Bioresorbable Scaffolds ◽  
Drug Eluting

From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI

2016 ◽  
Vol 13 (3) ◽  
pp. 271-286 ◽  
Author(s):  
Erhan Tenekecioglu ◽  
Christos Bourantas ◽  
Mohammad Abdelghani ◽  
Yaping Zeng ◽  
Rafael Cavalcante Silva ◽  
...  
Keyword(s):  
Drug Eluting Stents ◽  
New Horizons ◽  
Bioresorbable Scaffolds ◽  
Drug Eluting
Sign in / Sign up

Export Citation Format

Share Document